Ghost Tree Capital, LLC Regenxbio Inc. Transaction History
Ghost Tree Capital, LLC
- $267 Million
- Q3 2024
A detailed history of Ghost Tree Capital, LLC transactions in Regenxbio Inc. stock. As of the latest transaction made, Ghost Tree Capital, LLC holds 265,000 shares of RGNX stock, worth $1.95 Million. This represents 1.04% of its overall portfolio holdings.
Number of Shares
265,000
Previous 170,000
55.88%
Holding current value
$1.95 Million
Previous $1.99 Million
39.79%
% of portfolio
1.04%
Previous 0.81%
Shares
5 transactions
Others Institutions Holding RGNX
# of Institutions
191Shares Held
45.4MCall Options Held
184KPut Options Held
56.7K-
Black Rock Inc. New York, NY8.61MShares$63.4 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA4.79MShares$35.3 Million2.9% of portfolio
-
Jpmorgan Chase & CO New York, NY4.14MShares$30.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.99MShares$22 Million0.0% of portfolio
-
State Street Corp Boston, MA2.19MShares$16.1 Million0.0% of portfolio
About REGENXBIO Inc.
- Ticker RGNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,230,000
- Market Cap $318M
- Description
- REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...